Silexion Therapeutics Corp (NASDAQ:SLXN) does about 462.90K shares in volume on a normal day but saw 1558687 shares change hands in the recent trading day. The company now has a market cap of 3.79M USD. Its current market price is $0.98, marking an increase of 11.61% compared to the previous close of $0.88. The 52 week high reached by this stock is $13.56 whilst the lowest price level in 52 weeks is $0.83.
Silexion Therapeutics Corp (SLXN) has the current price is -92.77% off the 52-week high compared with 18.57% distance from its 52-week low. The 50-day simple moving average of the closing price is N/A. If we look at the stock’s price movements over the week, volatility stands at 20.94%, which increases to 33.28% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 18.73 to suggest the stock is oversold.
The current price level is -74.34%, -88.49%, and -90.18% away from its SMA20, SMA50, and SMA200 respectively, with the SLXN price moving above the 50-day SMA on current market day. Silexion Therapeutics Corp (SLXN) stock is down -32.88% over the week and -92.03% over the past month. Its price is -90.97% year-to-date and -90.01% over the past year.
Outstanding shares total 3.87M with insiders holding 93.76% of the shares and institutional holders owning 13.13% of the company’s common stock. The company has a return on investment of -20.64% and return on equity of -3.78%. The beta has a value of 0.08. Price to book ratio is 1.49.
